The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity

Regulatory Peptides

Volumn 165, Issue 1, 2010, Pages 102-110

  Shooshtarizadeh, Peiman ^a   Zhang, Dan ^a   Chich, Jean François ^a,b   Gasnier, Claire ^a   Schneider, Francis ^c   Haïkel, Youssef ^a   Aunis, Dominique ^a   Metz Boutigue, Marie Hélène ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INRA Institut National de la Recherche Agronomique   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Antimicrobial peptides; Chromogranins; Inflammation; Innate immunity; Secretogranins

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CALMODULIN; CATESTATIN; CHROMOFUNGIN; CHROMOGRANIN A; CHROMOGRANIN B; PHOSPHATIDYLSERINE; POLYPEPTIDE ANTIBIOTIC AGENT; PROCALCITONIN; SECRETOGRANIN II; UBIGRANIN; UNCLASSIFIED DRUG; VASOSTATIN 1;

AMINO TERMINAL SEQUENCE; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; BACTERIAL GROWTH; CARBOXY TERMINAL SEQUENCE; CATECHOLAMINE RELEASE; CELL MIGRATION; CELL STIMULATION; CHEMOTAXIS; DIMERIZATION; DNA BINDING; ENZYME INHIBITION; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MINIMUM INHIBITORY CONCENTRATION; MONOCYTE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; SEQUENCE ANALYSIS;

BOVINAE; FUNGI; MAMMALIA;

EID: 78649899816     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.11.014     Document Type: Review

References (73)

1. Helle K.B. The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects. Biol Rev Camb Philos Soc 2004, 79:769-794.
2. Metz-Boutigue M.H., Garcia-Sablone P., Hogue-Angeletti R., Aunis D. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur J Biochem 1993, 217:247-257.
3. Seidah N.G., Chretien M. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res 1999, 848:45-62.
4. Anouar Y., Yon L., Desmoucelles C., Leprince J., Breault L., Gallo-Payet N., et al. Identification of a novel secretogranin II-derived peptide in the adult and fetal human adrenal gland. Endocr Res 1998, 24:731-736.
5. Marksteiner J., Kirchmair R., Mahata S.K., Mahata M., Fischer-Colbrie R., Hogue-Angeletti R. Distribution of secretoneurin, a peptide derived from secretogranin II, in rat brain: an immunocytochemical and radioimmunological study. Neuroscience 1993, 54:923-944.
6. Yajima A., Ikeda M., Miyazaki K., Maeshima T., Narita N., Narita M. Manserin, a novel peptide from secretogranin II in the neuroendocrine system. NeuroReport 2004, 15:1755-1759.
7. Eiden L.E. Is chromogranin a prohormone?. Nature 1987, 325:301.
8. Tatemoto K., Efendic S., Mutt V., Makk G., Feistner G.J., Barchas J.D. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1986, 324:476-478.
9. Helle K.B., Serck-Hanssen G. The adrenal medulla: a model for studies of hormonal and neuronal storage and release mechanisms. Mol Cell Biochem 1975, 6:127-146.
10. Aardal S., Helle K.B., Elsayed S., Reed R.K., Serck-Hanssen G. Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J Neuroendocrinol 1993, 5:405-412.
11. Curry W.J., Shaw C., Johnston C.F., Thim L., Buchanan K.D. Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour. FEBS Lett 1992, 301:319-321.
12. Fasciotto B.H., Trauss C.A., Greeley G.H., Cohn D.V. Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion. Endocrinology 1993, 133:461-466.
13. Lugardon K., Chasserot-Golaz S., Kieffer A.E., Maget-Dana R., Nullans G., Kieffer B. Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide. J Biol Chem 2001, 276:35875-35882.
14. Mahata S.K., O'Connor D.T., Mahata M., Yoo S.H., Taupenot L., Wu H. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 1997, 100:1623-1633.
15. Strub J.M., Hubert P., Nullans G., Aunis D., Metz-Boutigue M.H. Antibacterial activity of secretolytin, a chromogranin B-derived peptide (614-626), is correlated with peptide structure. FEBS Lett 1996, 379:273-278.
16. Helle K.B., Corti A., Metz-Boutigue M.H., Tota B. The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties. Cell Mol Life Sci 2007, 64:2863-2886.
17. Brekke J.F., Osol G.J., Helle K.B. N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries. Regul Pept 2002, 105:93-100.
18. Corti A., Mannarino C., Mazza R., Angelone T., Longhi R., Tota B. Chromogranin A N-terminal fragments vasostatin-1 and the synthetic CGA 7-57 peptide act as cardiostatins on the isolated working frog heart. Gen Comp Endocrinol 2004, 136:217-224.
19. Amato A., Corti A., Serio R., Mule F. Inhibitory influence of chromogranin A N-terminal fragment (vasostatin-1) on the spontaneous contractions of rat proximal colon. Regul Pept 2005, 130:42-47.
20. Ghia J.E., Crenner F., Metz-Boutigue M.H., Aunis D., Angel F. The effect of a chromogranin A-derived peptide (CgA4-16) in the writhing nociceptive response induced by acetic acid in rats. Life Sci 2004, 75:1787-1799.
21. Ghia J.E., Crenner F., Rohr S., Meyer C., Metz-Boutigue M.H., Aunis D. A role for chromogranin A (4-16), a vasostatin-derived peptide, on human colonic motility. An in vitro study. Regul Pept 2004, 121:31-39.
22. Gasparri A., Sidoli A., Sanchez L.P., Longhi R., Siccardi A.G., Marchisio P.C. Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain. J Biol Chem 1997, 272:20835-20843.
23. Ratti S., Curnis F., Longhi R., Colombo B., Gasparri A., Magni F. Structure-activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells. J Biol Chem 2000, 275:29257-29263.
24. Ceconi C., Ferrari R., Bachetti T., Opasich C., Volterrani M., Colombo B. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart J 2002, 23:967-974.
25. Corti A., Ferrari R., Ceconi C. Chromogranin A and tumor necrosis factor-alpha (TNF) in chronic heart failure. Adv Exp Med Biol 2000, 482:351-359.
26. Radek K.A., Lopez-Garcia B., Hupe M., Niesman I.R., Elias P.M., Taupenot L. The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury. J Invest Dermatol 2008, 128:1525-1534.
27. Briolat J., Wu S.D., Mahata S.K., Gonthier B., Bagnard D., Chasserot-Golaz S. New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A. Cell Mol Life Sci 2005, 62:377-385.
28. Lugardon K., Raffner R., Goumon Y., Corti A., Delmas A., Bulet P. Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A. J Biol Chem 2000, 275:10745-10753.
29. Metz-Boutigue M.H., Goumon Y., Lugardon K., Strub J.M., Aunis D. Antibacterial peptides are present in chromaffin cell secretory granules. Cell Mol Neurobiol 1998, 18:249-266.
30. Strub J.M., Goumon Y., Lugardon K., Capon C., Lopez M., Moniatte M. Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules. J Biol Chem 1996, 271:28533-28540.
31. Sternberg E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006, 6:318-328.
32. Call G.B., Husein O.F., McIlmoil C.J., Adams A., Heckmann R.A., Judd A.M. Bovine adrenal cells secrete interleukin-6 and tumor necrosis factor in vitro. Gen Comp Endocrinol 2000, 118:249-261.
33. The Universal Protein Resource (UniProt) 2009. Nucleic Acids Res 2009, 37:D169-D174.
34. Wang Z., Wang G. APD: the antimicrobial peptide database. Nucleic Acids Res 2004, 32:D590-D592.
35. Hoffmann J.A., Kafatos F.C., Janeway C.A., Ezekowitz R.A. Phylogenetic perspectives in innate immunity. Science 1999, 284:1313-1318.
36. Maget-Dana R., Metz-Boutigue M.H., Helle K.B. The N-terminal domain of chromogranin A (CgA1-40) interacts with monolayers of membrane lipids of fungal and mammalian compositions. Ann N Y Acad Sci 2002, 971:352-354.
37. Brosig B., Langosch D. The dimerization motif of the glycophorin A transmembrane segment in membranes: importance of glycine residues. Protein Sci 1998, 7:1052-1056.
38. Yoo S.H. Identification of the Ca(2+)-dependent calmodulin-binding region of chromogranin A. Biochemistry 1992, 31:6134-6140.
39. Torres G.E., Carneiro A., Seamans K., Fiorentini C., Sweeney A., Yao W.D. Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem 2003, 278:2731-2739.
40. Blois A., Holmsen H., Martino G., Corti A., Metz-Boutigue M.H., Helle K.B. Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine. Regul Pept 2006, 134:30-37.
41. Maget-Dana R. The monolayer technique: a potent tool for studying the interfacial properties of antimicrobial and membrane-lytic peptides and their interactions with lipid membranes. Biochim Biophys Acta 1999, 1462:109-140.
42. Taylor C.V., Taupenot L., Mahata S.K., Mahata M., Wu H., Yasothornsrikul S. Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules. J Biol Chem 2000, 275:22905-22915.
43. Biswas N., Rodriguez-Flores J.L., Courel M., Gayen J.R., Vaingankar S.M., Mahata M. Cathepsin L colocalizes with chromogranin a in chromaffin vesicles to generate active peptides. Endocrinology 2009, 150:3547-3557.
44. Oppenheim F.G., Yang Y.C., Diamond R.D., Hyslop D., Offner G.D., Troxler R.F. The primary structure and functional characterization of the neutral histidine-rich polypeptide from human parotid secretion. J Biol Chem 1986, 261:1177-1182.
45. Agerberth B., Lee J.Y., Bergman T., Carlquist M., Boman H.G., Mutt V. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem 1991, 202:849-854.
46. Valore E.V., Ganz T. Posttranslational processing of defensins in immature human myeloid cells. Blood 1992, 79:1538-1544.
47. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol 2005, 3:238-250.
48. Jenssen H., Hamill P., Hancock R.E. Peptide antimicrobial agents. Clin Microbiol Rev 2006, 19:491-511.
49. Zhang D., Shooshtarizadeh P., Laventie B.J., Colin D.A., Chich J.F., Vidic J. Two chromogranin A-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2. PLoS ONE 2009, 4:e4501.
50. Herrero C.J., Ales E., Pintado A.J., Lopez M.G., Garcia-Palomero E., Mahata S.K. Modulatory mechanism of the endogenous peptide catestatin on neuronal nicotinic acetylcholine receptors and exocytosis. J Neurosci 2002, 22:377-388.
51. Angelone T., Quintieri A.M., Brar B.K., Limchaiyawat P.T., Tota B., Mahata S.K. The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. Endocrinology 2008, 149:4780-4793.
52. Jean-Francois F., Khemtemourian L., Odaert B., Castano S., Grelard A., Manigand C. Variability in secondary structure of the antimicrobial peptide Cateslytin in powder, solution, DPC micelles and at the air-water interface. Eur Biophys J 2007, 36:1019-1027.
53. Jean-Francois F., Castano S., Desbat B., Odaert B., Roux M., Metz-Boutigue M.H. Aggregation of cateslytin beta-sheets on negatively charged lipids promotes rigid membrane domains. A new mode of action for antimicrobial peptides?. Biochemistry 2008, 47:6394-6402.
54. Jean-Francois F., Elezgaray J., Berson P., Vacher P., Dufourc E.J. Pore formation induced by an antimicrobial peptide: electrostatic effects. Biophys J 2008, 95:5748-5756.
55. Jean-Francois F., Desbat B, Dufourc E.J. Selectivity of cateslytin for fungi: the role of acidic lipid-ergosterol membrane fluidity in antimicrobial action. Faseb J 2009, 23:3692-3701.
56. Henriques S.T., Melo M.N., Castanho M.A. Cell-penetrating peptides and antimicrobial peptides: how different are they?. Biochem J 2006, 399:1-7.
57. Egger M., Beer A.G., Theurl M., Schgoer W., Hotter B., Tatarczyk T. Monocyte migration: a novel effect and signaling pathways of catestatin. Eur J Pharmacol 2008, 598:104-111.
58. Reinisch N., Kirchmair R., Kahler C.M., Hogue-Angeletti R., Fischer-Colbrie R., Winkler H. Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett 1993, 334:41-44.
59. O'Connor D.T., Kailasam M.T., Kennedy B.P., Ziegler M.G., Yanaihara N., Parmer R.J. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 2002, 20:1335-1345.
60. Taupenot L., Harper K.L., O'Connor D.T. The chromogranin-secretogranin family. N Engl J Med 2003, 348:1134-1149.
61. Cerra M.C., Gallo M.P., Angelone T., Quintieri A.M., Pulera E., Filice E. The homologous rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide. Faseb J 2008, 22:3992-4004.
62. Capellino S., Lowin T., Angele P., Falk W., Grifka J., Straub R.H. Increased chromogranin A levels indicate sympathetic hyperactivity in patients with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 2008, 35:91-99.
63. Hironaka M., Ansai T., Soh I., Ishisaka A., Awano S., Yoshida A. Association between salivary levels of chromogranin A and periodontitis in older Japanese. Biomed Res 2008, 29:125-130.
64. Zhang D., Lavaux T., Voegeli A.C., Lavigne T., Castelain V., Meyer N. Prognostic value of chromogranin A at admission in critically ill patients: a cohort study in a medical intensive care unit. Clin Chem 2008, 54:1497-1503.
65. Zhang D., Lavaux T., Sapin R., Lavigne T., Castelain V., Aunis D. Serum concentration of chromogranin A at admission: an early biomarker of severity in critically ill patients. Ann Med 2009, 41:38-44.
66. Fitch P.M., Roghanian A., Howie S.E., Sallenave J.M. Human neutrophil elastase inhibitors in innate and adaptive immunity. Biochem Soc Trans 2006, 34:279-282.
67. Roghanian A., Sallenave J.M. Neutrophil elastase (NE) and NE inhibitors: canonical and noncanonical functions in lung chronic inflammatory diseases (cystic fibrosis and chronic obstructive pulmonary disease). J Aerosol Med Pulm Drug Deliv 2008, 21:125-144.
68. Metz-Boutigue M.H., Kieffer A.E., Goumon Y., Aunis D. Innate immunity: involvement of new neuropeptides. Trends Microbiol 2003, 11:585-592.
69. Iacangelo A., Affolter H.U., Eiden L.E., Herbert E., Grimes M. Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues. Nature 1986, 323:82-86.
70. Schlesinger D.H., Goldstein G., Niall H.D. The complete amino acid sequence of ubiquitin, an adenylate cyclase stimulating polypeptide probably universal in living cells. Biochemistry 1975, 14:2214-2218.
71. Bauer J.W., Fischer-Colbrie R. Primary structure of bovine chromogranin B deduced from cDNA sequence. Biochim Biophys Acta 1991, 1089:124-126.
72. Strub J.M., Garcia-Sablone P., Lonning K., Taupenot L., Hubert P., Van Dorsselaer A. Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity. Eur J Biochem 1995, 229:356-368.
73. Fischer-Colbrie R., Gutierrez J., Hsu C.M., Iacangelo A., Eiden L.E. Sequence analysis, tissue distribution and regulation by cell depolarization, and second messengers of bovine secretogranin II (chromogranin C) mRNA. J Biol Chem 1990, 265:9208-9213.